IRIDEX Corporation (IRIX)

Market Cap	27.28M
Revenue (ttm)	48.43M
Net Income (ttm)	-11.04M
Shares Out	16.64M
EPS (ttm)	-0.68
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,271
Open	1.695
Previous Close	1.710
Day's Range	1.635 - 1.723
52-Week Range	1.270 - 3.650
Beta	0.82
Analysts	Hold
Price Target	2.00 (+21.95%)
Earnings Date	Nov 12, 2024

About IRIX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retino...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 15, 1996
• Employees: 111
• Stock Exchange: NASDAQ
• Ticker Symbol: IRIX
• Website: https://www.iridex.com

Financial Performance

In 2023, IRIDEX's revenue was $51.87 million, a decrease of -8.96% compared to the previous year's $56.97 million. Losses were -$9.57 million, 26.8% more than in 2022.

Analyst Forecast

According to one analyst, the rating for IRIX stock is "Hold" and the 12-month stock price forecast is $2.0.

Price Target

$2.0

(21.95% upside)

Analyst Consensus: Hold